Category: Biomarkers
United States Biomarkers
-
2022-2026 North America Cancer Diagnostics Market in the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... from LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists ... Read More
-
United States Liquid Biopsy Market, By Product & Services (Assay Kits, Instruments, Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Others), By Technology (Multi-gene Parallel Analysis using NGS v/s Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027
... Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027 The United States liquid biopsy market is projected to ... Read More
-
2022-2026 U.S. Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S. cancer diagnostics markets, ... Read More
-
2022-2026 Global Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities - USA, Europe, Japan - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the ... Read More
-
2022-2026 North America Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities - USA, Canada, Mexico - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ... Read More
-
2022-2026 Global Cancer Diagnostics Market Database for the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing ... Read More
-
2022-2026 US Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 North America Cancer Diagnostics Market Database for the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies ... Read More
-
U.S. Solid Tumor Testing Market - A Country Analysis: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis and Forecast, 2022-2032
... Overview The U.S. solid tumor testing market was estimated to be at $9,498.8 million in 2021, which is expected to grow with a CAGR of 6.19% during the forecast period 2022-2032 and reach $18,287.6 million ... Read More
-
Global Cancer Diagnostics Market Segmentation Analysis: US, Europe, Japan-Cancer Clinics, Commercial Labs, Hospitals, Physician Offices-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... is based on a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and ... Read More
-
Immunodiagnostics Market: US, Europe, Japan-Spot Fast-Growing Market Segments-Supplier Shares and Segment Forecasts for over 100 Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, and Drugs of Abuse Tests
... a strategic analysis of major business opportunities emerging in the global clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the U.S., five major European countries (France, Germany, ... Read More
-
United States Cancer Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... treatments for cancer in the country and increasing usage of biomarkers in drug development. The rising number of cancer cases is creating tremendous opportunities for market players. The major market players are focusing on R&D ... Read More
-
2022-2026 Global Cancer Diagnostics Market Opportunities for Major Tumor Markers: USA, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging ... Read More
-
2022-2026 North America Cancer Diagnostics Market Opportunities for Major Tumor Markers: US, Canada, Mexico - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and ... Read More
-
2022-2026 US Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S. cancer diagnostics markets, reviews current and emerging assays; analyzes potential ... Read More
Research Assistance
